Zeev Modular Dental Implants

17 Tchelet St., Misgav Business Park, 2017400, Israel

© 2019 All rights reserved to Zeev Implants

Website by: Anat Belinson


Founded - December 2015

  • Solution to an un-met need: Zeev’s novel dental implant is based on a modular design presenting a real repair alternative for Peri-implantitis

  • The company targets a huge & growing Dental Implants  market –

       $5 billion global market with 7% CAGR

  • Development is complete, demonstrated proof of concept

  • CE and FDA Clearance expected 2019

  • Strong Issued IP

  • Investors: Trendlines Group ; Israel Innovation Authority


Issued patent- Israel, Europa; US

Second patent - on process


  • Successful Biomechanical test results at prestigious institutions.

Road map

      H1 2019 FIH clinical study;       

          2019 CE Clearance; 

                   FDA 510K Approval

By using Zeev's unique modular dental implants –  

  • Gain confidence by improved implant management options

  • Eliminates total implant extraction

  • Ability to re-use the original crown

  • Reduces complications, pain, chair-time and costs.



Dr. Pinchas Kfir, DMD, MEI

Founder, CEO, Director

Dentist with over 25 years’ experience in dental implantology. 
Experienced entrepreneur and co-founder of start-ups in dental field.
Attorney-at-law Bar-Ilan University, Israel.

MEI - Entrepreneurship and Innovation, Swinburne University of Technology, Australia.

Lior Hazan, BSc.


15 years of experience in R&D and manufacturing in the medical device industry; previously held executive positions at leading Israeli dental implant companies.


Dr. Edit Goldberg, DMD, MBA

Trained dentist, over 15 years’ experience in the medical device field;

CEO at Escala Medical, director at Elcam Medical

Barak Singer, LLB, BBA

CEO, Trendlines Incubators Israel

Over 15 years of experience in management, business development, investment banking, and venture capital - VP Business Development Trendlines Incubators Israel ;Managing Director, Co-Head of Investment Banking, and Head of Healthcare at Tamir Fishman & Co., representing the Royal Bank of Canada’s (NYSE:RY) investment banking arm in Israel, RBC Capital Markets.; VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix; VP Business Development at Xenia Venture Capital; Co-Founder and CEO at Or Capital Healthcare Partners.

Adv. Zvi Fisher

Co-founder Levin Fisher law offices